Log in to save to my catalogue

Identification and management of cardiometabolic risk in subjects with schizophrenia spectrum disord...

Identification and management of cardiometabolic risk in subjects with schizophrenia spectrum disord...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3ba644b1bd3c4029bf48c464d3e4de69

Identification and management of cardiometabolic risk in subjects with schizophrenia spectrum disorders: A Delphi expert consensus study

About this item

Full title

Identification and management of cardiometabolic risk in subjects with schizophrenia spectrum disorders: A Delphi expert consensus study

Publisher

England: Cambridge University press

Journal title

European psychiatry, 2021-01, Vol.64 (1), p.e7-e7, Article e7

Language

English

Formats

Publication information

Publisher

England: Cambridge University press

More information

Scope and Contents

Contents

Patients with schizophrenia spectrum disorders (SSD) have worse physical health and reduced life expectancy compared to the general population. In 2009, the European Psychiatric Association, the European Society of Cardiology and the European Association for the Study of Diabetes published a position paper aimed to improve cardiovascular and diabet...

Alternative Titles

Full title

Identification and management of cardiometabolic risk in subjects with schizophrenia spectrum disorders: A Delphi expert consensus study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_3ba644b1bd3c4029bf48c464d3e4de69

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3ba644b1bd3c4029bf48c464d3e4de69

Other Identifiers

ISSN

0924-9338

E-ISSN

1778-3585

DOI

10.1192/j.eurpsy.2020.115

How to access this item